CMO to put old Pfizer plant in Tennessee to use with Amerigen pact
UPM will produce two generic drugs for Amerigen Pharmaceuticals at a former Pfizer facility under a new 10 year supply contract.
Archives for April 6, 2014
Survey: Supply chain execs to up clinical trial logistics spend
Almost two-thirds of supply chain executives plan to increase their expenditure in clinical trial logistics over the next two years, according to an industry survey conducted by Marken.
Mid-size CROs see uptick in clinical trial wins
As smaller biotech, pharma and medical device companies seem keen to expand R&D, they also seem to be consistently turning to mid-size CROs to run their trials.
UPDATE
Sun Pharma's $3.2bn Ranbaxy acq: 'Compliance first, synergies later'
Regulatory compliance will be the number one focus for Sun Pharma, the company says, following its $3.2bn (€2.3bn) takeover of Indian generics firm Ranbaxy.
EMA slashes fees for small drug developers
The EMA (European Medicines Agency) has cut what it charges small and medium-sized enterprises (SMEs) and micro businesses to help them comply with regulations once their drugs are approved.
WHO calls for more industry invesment in tick-borne disease treatments
Better data on the global burden of tick-borne illnesses may encourage profit driven drugmakers to spend their R&D budgets on much needed treatments says the WHO.